Gauging heterogeneity in primary versus recurrent glioblastoma

per Niclou, Simone P.
Publicat a Neuro Oncol (2015)

Revival of the VEGF ligand family?

per Niclou, Simone P
Publicat a Neuro Oncol (2018)

Dual blockade of STAT3 and EGFR: a key to unlock drug resistance in glioblastoma?

per Fritah, Sabrina, Niclou, Simone P
Publicat a Neuro Oncol (2020)

Is there a prominent role for MR spectroscopy in the clinical management of brain tumors?

per Keunen, Olivier, Niclou, Simone P
Publicat a Neuro Oncol (2020)

Turning strength into weakness: protein degradation and autophagy as therapeutic targets in glioblastoma?

per Niclou, Simone P, Golebiewska, Anna
Publicat a Neuro Oncol (2021)

Databases for lncRNAs: a comparative evaluation of emerging tools

per Fritah, Sabrina, Niclou, Simone P., Azuaje, Francisco
Publicat 2014

Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma

per Azuaje, Francisco, Tiemann, Katja, Niclou, Simone P
Publicat a Cell Commun Signal (2015)

Slit2 Is a Repellent for Retinal Ganglion Cell Axons

per Niclou, Simone P., Jia, Li, Raper, Jonathan A.
Publicat a J Neurosci (2000)

Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma

per Pires-Afonso, Yolanda, Niclou, Simone P., Michelucci, Alessandro
Publicat a Int J Mol Sci (2020)

PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species

per Demeure, Kevin, Duriez, Elodie, Domon, Bruno, Niclou, Simone P.
Publicat 2014

Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system

per Ehlert, Erich M, Eggers, Ruben, Niclou, Simone P, Verhaagen, Joost
Publicat 2010

A novel multilayer immunoisolating encapsulation system overcoming protrusion of cells

per Bhujbal, Swapnil V., de Haan, Bart, Niclou, Simone P., de Vos, Paul
Publicat 2014

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy

per Klein, Eliane, Hau, Ann-Christin, Oudin, Anaïs, Golebiewska, Anna, Niclou, Simone P.
Publicat a Front Oncol (2020)

Highlights from the Literature

per Viapiano, Mariano, Khasraw, Mustafa, Huse, Jason, Ghosh, Sourav, Niclou, Simone P, Golebiewska, Anna
Publicat a Neuro Oncol (2021)

Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs

per Du Four, Stephanie, Maenhout, Sarah K, Niclou, Simone P, Thielemans, Kris, Neyns, Bart, Aerts, Joeri L
Publicat a Am J Cancer Res (2016)

IN SITU METABOLIC PROFILING SHEDS LIGHT ON OXIDATIVE STRESS PATHWAYS IN IDH1 MUTANT OLIGODENDROGLIOMA

per Niclou, Simone P., Fack, Fred, Hochart, Guillaume, Oudin, Anais, Leenders, William, Gottlieb, Eyal, Bjerkvig, Rolf, Stauber, Joachim
Publicat 2014

Formation of Composite Endothelial Cell–Mesenchymal Stem Cell Islets: A Novel Approach to Promote Islet Revascularization

per Johansson, Ulrika, Rasmusson, Ida, Niclou, Simone P., Forslund, Naomi, Gustavsson, Linda, Nilsson, Bo, Korsgren, Olle, Magnusson, Peetra U.
Publicat 2008

Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?

per Fathpour, Pakzad, Obad, Nina, Espedal, Heidi, Stieber, Daniel, Keunen, Olivier, Sakariassen, Per Ø., Niclou, Simone P., Bjerkvig, Rolf
Publicat 2014

Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas

per Nesseler, Jean Philippe, Schaue, Dorthe, McBride, William H., Lee, Mi-Heon, Kaprealian, Tania, Niclou, Simone P., Nickers, Philippe
Publicat a Adv Radiat Oncol (2018)

MAPPING THE GLIOBLASTOMA METABOLOME AFTER BEVACIZUMAB THERAPY BY 13C6-GLUCOSE METABOLOMIC FLUX ANALYSIS.

per Bjerkvig, Rolf, Fack, Fred, Frezza, Christian, Keunen, Olivier, Stieber, Daniel, Lund-Johansen, Morten, Miletic, Hrvoje, Gottlieb, Eyal, Niclou, Simone P.
Publicat 2014